Previous authors have shown that tumor-specific prognostic factors such as histological grade, Ki-67 index/mitotic count, stage/size, nodal status, and site of origin influences the frequency of surveillance arranged by providers [7]. This evidence concerns the gene MKI67 and neoplasm.